ログイン

SUMMATIVE PART 2

SUMMATIVE PART 2
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    The key structural difference that distinguishes immunoglobulin subclasses is the: A. Number of domains B. Stereometry of the hypervariable region C. The sequence of the constant regions D. Covalent linkage of the light chains

    C. The sequence of the constant regions

  • 2

    lmmunoglobulin classes are differentiated according to the molecular structure of: A. Light chains B. Heavy chains C. Fab fragment D. Fc fragment

    B. Heavy chains

  • 3

    .A 54-year-old female previous smoker presents with a recent history of fever, swollen joints, and morning stiffness. § Laboratory results indicate elevated C-reactive protein, positive cyclic citrullinated peptide of 205 units (cut-off: 20 units), speckled ANA pattern (titer 1:320), and negative rheumatoid factor. What is the most likely diagnosis? A. Reactive arthritis B. Rheumatoid arthritis C. Systemic sclerosis D. Sjogren syndrome

    B. Rheumatoid arthritis

  • 4

    Which of the following is used for the confirmation of infection with HIV-1? A. Western blot (immunoblot) assay B. ELISA C. Complement fixation D. p24 Antigen testing

    A. Western blot (immunoblot) assay

  • 5

    Which technique is used for the confirmation of infection with HIV-1 and HIV-2? A. Western blot (immunoblot) assay B. ELISA C. FDA-approved NAT D. p24 Antigen testing

    C. FDA-approved NAT

  • 6

    Clinical assays for tumor markers are most important for: A. Screening for the presence of cancer B. Monitoring the course of a known cancer C. Confirming the absence of disease D. Identifying patients at risk for cancer

    B. Monitoring the course of a known cancer

  • 7

    . In general, in which of the following situations is the analysis of a tumor marker most useful? A. Testing for recurrence B. Prognosis C. Screening D. Diagnosis

    A. Testing for recurrence

  • 8

    The chemical composition of an antibody is: A. Protein B. Lipid C. Carbohydrate D. Glycoprotein

    D. Glycoprotein

  • 9

    What is the most common clinical incident that results in alloantibody production? A. Viral infection B. Solid tumor C. Red cell transfusion D. Autoimmune disease

    C. Red cell transfusion

  • 10

    What antibodies are present in polyspecific AHG reagent? A. Anti-IgG B. Anti-IgM and anti-IgG C. Anti-IgG and anti-C3d D. Anti-C3d

    C. Anti-IgG and anti-C3d

  • 11

    Which of the following medications is most likely to cause production of AUTOANTIBODIES? A. Penicillin B. Cephalosporin C. Methyldopa D. Tetracycline

    C. Methyldopa

  • 12

    Red cells from a recently transfused patient were DAT positive when tested with anti-IgG. Screen cells and a panel performed on a patient’s serum showed very weak reactions with inconclusive results. What procedure could help to identify the antibody? A. Elution followed by a panel on the eluate B. Adsorption followed by a panel on the adsorbed serum C. Enzyme panel D. Antigen typing the patient’s red cells

    A. Elution followed by a panel on the eluate

  • 13

    The procedure that removes intact antibodies from the red cell membranes is: A. Autoadsorption B. Enzyme pretreatment C. Neutralization D. Elution

    D. Elution

  • 14

    Crossmatch results at the antiglobulin phase were negative. When 1 drop of check cells was added, NO AGGLUTINATION was seen. The most likely explanation is that the: A. Red cells were overwashed B. Residual patient serum inactivated the AHG reagent C. Centrifuge speed was set too high D. Laboratorian did not add enough check cells

    B. Residual patient serum inactivated the AHG reagent

  • 15

    Autoantibodies demonstrating blood group specificity in warm autoimmune hemolytic anemia are associated more often with which blood group system? A. Rh B. I C. P D. Fy

    A. Rh

  • 16

    Which antibody is frequently seen in patients with warm autoimmune hemolytic anemia? A. Anti-Jka B. Anti-e C. Anti-K D. Anti-Fyb

    B. Anti-e

  • 17

    Many enhancement media used in the blood bank promote hemagglutination in the presence of lgG antibodies by reducing which of the following? A. Hydrophilic forces B. Low ionic potential C. van der Waals forces D. Zeta potential

    D. Zeta potential

  • 18

    Low ionic strength saline (LISS) acts as an enhancement medium and facilitates antibody uptake by: A. Activating complement B. Increasing flexibility in hinge region C. Removing water molecules D. Reducing zeta potential

    D. Reducing zeta potential

  • 19

    Which antibody would not be detected by group O screening cells? A. Anti-N B. Anti-A1 C. Anti-Dia D. Anti-k

    B. Anti-A1

  • 20

    Screening cells, major crossmatch, and patient autocontrol are positive in all phases. Identify the problem. A. Specific cold alloantibody B. Specific cold autoantibody C. Abnormal protein or nonspecific autoantibody D. Cold and warm alloantibody mixture

    C. Abnormal protein or nonspecific autoantibody

  • 21

    What corrective action should be taken when rouleaux causes positive test results? A. Perform a saline replacement technique B. Perform an autoabsorption C. Run a panel D. Perform an elution

    A. Perform a saline replacement techniqu

  • 22

    . Screening cells and major crossmatch are positive on IS only, and the autocontrol is negative. Identify the problem. A. Cold alloantibody B. Cold autoantibody C. Abnormal protein D. Antibody mixture

    A. Cold alloantibody

  • 23

    Which of the following describes the expression of most blood group inheritance? A. Dominant B. Sex-linked C. Recessive D. Codominant

    D. Codominant

  • 24

    Which genotype(s) will give rise to the Bombay phenotype? A. HH only B. HH and Hh C. Hh and hh D. hh only

    D. hh only

  • 25

    What should be done if all forward and reverse ABO results as well as the autocontrol are positive? A. Wash the cells with warm saline, autoadsorb the serum at 4°C B. Retype the sample using a different lot number of reagents C. Use polyclonal typing reagents D. Report the sample as group AB

    A. Wash the cells with warm saline, autoadsorb the serum at 4°C

  • 26

    A patient types as AB positive. Two units of blood have been ordered by the physician. Currently, the inventory shows no AB units, 10 A-positive units, 1 Anegative unit, 5 B-positive units, and 20 O-positive units. Which should be set up for the major crossmatch? A. A-positive units B. O-positive units C. B-positive units D. Call another blood supplier for type-specific blood

    A. A-positive units

  • 27

    A physician orders 2 units of leukocyte-reduced red blood cells. The patient is a 55-year-old male with anemia. He types as an AB negative, and his antibody screen is negative. There is only 1 unit of AB negative in inventory. What is the next blood type that should be given? A. AB positive (patient is male) B. A negative C. B negative D. O negative

    B. A negative

  • 28

    In an emergency situation, Rh-negative red cells are transfused into an Rh-positive person of the genotype CDe/CDe. The first antibody most likely to develop is: A. Anti-c B. Anti-d C. Anti-e D. Anti-E

    A. Anti-c

  • 29

    What antibodies could an R1R1 make if exposed to R2R2 blood? A. Anti-e and anti-C B. Anti-E and anti-c C. Anti-E and anti-C D. Anti-e and anti-c

    B. Anti-E and anti-c

  • 30

    What techniques are necessary for weak D testing? A. Saline + 22°C incubation B. Albumin or LISS + 37°C incubation C. Saline + 37°C incubation D. 37°C incubation + IAT

    D. 37°C incubation + IAT

  • 31

    RhIg (Rhogam) is indicated for: A. Mothers who have anti-D B. Infants who are Rh-negative C. Infants who have anti-D D. Mothers who are Rh-negative

    D. Mothers who are Rh-negative

  • 32

    .RhIG should be administered within how many hours of delivery? A. 4 B. 48 C. 72 D. 96

    C. 72

  • 33

    Which of the following antigens is poorly expressed on cord blood cells? A. K B. M C. Leb D. D

    C. Leb

  • 34

    Which of the following is characteristic of anti-i? A. Often associated with hemolytic disease of the newborn B. Reacts best at 37ºC C. Reacts best at room temperature or 4ºC D. Is usually IgG

    C. Reacts best at room temperature or 4ºC

  • 35

    PAROXYSMAL COLD HEMOGLOBINURIA (PCH) is associated with antibody specificity toward which of the following? A. Kell system antigens B. Duffy system antigens C. P antigen D. I antigen

    C. P antigen

  • 36

    In the DONATH-LANDSTEINER TEST, patient’s serum are incubated at various temperatures with: A. Group O RBCs that express the P antigen B. Group O RBCs that express the P1 antigen C. Group AB RBCs that express the P antigen D. Group AB RBCs that express the P1 antigen

    A. Group O RBCs that express the P antigen

  • 37

    Excluding ABO, __ is rated second only to D in immunogenicity. A. Kell B. Cellano C. Duffy D. Kidd

    A. Kell

  • 38

    The K (KEL1) antigen is: A. Absent from the red cells of neonates B. Strongly immunogenic C. Destroyed by enzymes D. Has a frequency of 50% in the random population

    B. Strongly immunogenic

  • 39

    The k (Cellano) antigen is a high-frequency antigen and is found on most red cells. How often would one expect to find the corresponding antibody? A. Often B. Rarely C. It depends upon the population D. Impossible to determine without consulting regional blood group antigen charts

    B. Rarely

  • 40

    An individual has been sensitized to the k antigen and has produced anti-k. What is her most probable Kell system genotype? A. KK B. Kk C. kk D. K0K0

    A. KK

  • 41

    An antibody commonly associated with delayed transfusion reactions is: A. Anti-Lua B. Anti-S C. Anti-Jkb D. Anti-M

    C. Anti-Jkb

  • 42

    What blood group system antibodies are commonly associated with delayed hemolytic transfusion reactions? A. Rh c B. MNS C. ABO D. Kidd

    D. Kidd

  • 43

    What procedure would help to distinguish between an anti-Fya and anti-Jka in an antibody mixture? A. Lowering the pH of the patient’s serum B. Using a thiol reagent C. Testing at colder temperatures D. Ficin-treated panel cells

    D. Ficin-treated panel cells

  • 44

    Which of the following antibodies characteristically gives a refractile mixed-field appearance? A. Anti-K B. Anti-Dia C. Anti-Sda D. Anti-s

    C. Anti-Sda

  • 45

    A patient has symptoms indicating a possible hemolytic transfusion reaction. What should be done immediately? A. Stop the transfusion and discard the unit B. Contact the patient's doctor to ask if the transfusion should be stopped C. Stop the transfusion and call the patient's doctor to report the reaction D. Have patient blood samples sent to the lab to investigate the reaction

    C. Stop the transfusion and call the patient's doctor to report the reaction

  • 46

    FATAL TRANSFUSION reactions are mostly caused by? A. Serologic errors B. Improper storage of blood C. Clerical errors D. Improper handling of the product

    C. Clerical errors

  • 47

    Some blood group antibodies characteristically hemolyze appropriate red cells in the presence of: A. Complement B. Anticoagulants C. Preservatives D. Penicillin

    A. Complement

  • 48

    PAIN AT INFUSION SITE and hypotension are observed with what type of reaction? A. Acute hemolytic transfusion reaction B. Allergic reaction C. Delayed hemolytic transfusion reaction D. Febrile nonhemolytic reaction

    A. Acute hemolytic transfusion reaction

  • 49

    Hypotension, nausea, flushing, fever and chills are symptoms of which of the following transfusion reactions? A. Allergic B. Circulatory overload C. Hemolytic D. Anaphylactic

    C. Hemolytic

  • 50

    Hemoglobinuria, hypotension and generalized bleeding are symptoms of which of the following transfusion reactions? A. Allergic B. Circulatory overload C. Hemolytic D. Anaphylactic

    C. Hemolytic

  • 51

    The most serious hemolytic transfusion reactions are due to incompatibility in which of the following blood group systems? A. ABO B. Rh C. MN D. Duffy

    A. ABO

  • 52

    What would be the result of group A blood given to an O patient? A. Nonimmune transfusion reaction B. Immediate hemolytic transfusion reaction C. Delayed hemolytic transfusion reaction D. Febrile nonhemolytic transfusion reaction

    B. Immediate hemolytic transfusion reaction

  • 53

    A patient has a hemolytic reaction to blood transfused 8 days ago. What is the most likely cause? A. Immediate, nonimmunologic probably due to volume overload B. Delayed immunologic, probably due to an antibody such as anti-Jka C. Delayed nonimmunologic, probably due to iron overload D. Immediate, immunologic, probably due to clerical error, ABO incompatibility

    B. Delayed immunologic, probably due to an antibody such as anti-Jka

  • 54

    In a DELAYED TRANSFUSION REACTION, the causative antibody is generally too weak to be detected in routine compatibility testing and antibody screening tests, but is typically detectable at what point after transfusion? A. 3 - 6 hours B. 3 - 7 days C. 60 - 90 days D. After 120 days

    B. 3 - 7 days

  • 55

    An unexplained fall in hemoglobin and mild jaundice in a patient transfused with Red Blood Cells 1 week previously would most likely indicate: A. Paroxysmal nocturnal hemoglobinuria B. Posttransfusion hepatitis infection C. Presence of HLA antibodies D. Delayed hemolytic transfusion reaction

    D. Delayed hemolytic transfusion reaction

  • 56

    Fever and chills are symptoms of which of the following transfusion reactions? A. Citrate toxicity B. Circulatory overload C. Allergic D. Febrile

    D. Febrile

  • 57

    Symptoms of dyspnea, hypoxemia, and pulmonary edema within 6 hours of transfusion is most likely which type of reaction? A. Anaphylactic B. Hemolytic C. Febrile D. TRALI

    D. TRALI

  • 58

    What may be found in the serum of a person who is exhibiting signs of TRALI (transfusion-related acute lung injury)? A. Red blood cell alloantibody B. IgA antibody C. Anti-leukocyte antibody D. Allergen

    C. Anti-leukocyte antibody

  • 59

    Hives and itching are symptoms of which of the following transfusion reactions? A. Febrile B. Allergic C. Circulatory overload D. Bacterial

    B. Allergic

  • 60

    Which of the following transfusion reactions occurs after infusion of only a few milliliters of blood and gives no history of fever? A. Febrile B. Circulatory overload C. Anaphylactic D. Hemolytic

    C. Anaphylactic

  • 61

    Anaphylactic reactions to transfusion are usually caused by: A. Anti-IgA in an IgA-deficient recipient B. Anti-IgG in an IgA-deficient C. IgA deficiency D. IgG deficiency

    A. Anti-IgA in an IgA-deficient recipient

  • 62

    Which of the following transfusion reactions is characterized by high fever, shock, hemoglobinuria, DIC and renal failure? A. Bacterial contamination B. Circulatory overload C. Febrile D. Anaphylactic

    A. Bacterial contamination

  • 63

    Coughing, hypoxemia and difficult breathing are symptoms of which of the following transfusion reactions? A. Febrile B. Allergic C. TACO D. Hemolytic

    C. TACO

  • 64

    Congestive heart failure, severe headache and/or peripheral edema occurring soon after transfusion is indicative of which type of transfusion reaction? A. Hemolytic B. Febrile C. Anaphylactic D. TACO

    D. TACO

  • 65

    Which of the following patient groups is at risk of developing graft-versus-host disease? A. Full-term infants B. Patients with history of febrile transfusion reactions C. Patients with a positive direct antiglobulin test D. Recipients of blood donated by immediate family members

    D. Recipients of blood donated by immediate family members

  • 66

    The most frequent transfusion-associated disease complication of blood transfusions is: A. Cytomegalovirus (CMV) B. Syphilis C. Hepatitis D. HIV-1/2

    C. Hepatitis

  • 67

    When evaluating a possible delayed hemolytic reaction, what is the best sample to use for bilirubin determination? A. 6 hours posttransfusion B. 12 hours posttransfusion C. 24 hours posttransfusion D. 48 hours posttransfusion

    A. 6 hours posttransfusion

  • 68

    What is the primary reason that infectious agents can be transmitted following blood transfusion? A. Pathogen reduction technology failure B. Donor in the window period of early infection C. Leukocyte-reduction failure D. Donor history questionnaire not completed

    B. Donor in the window period of early infection

  • 69

    . What may be done to RBCs before transfusion to a patient with cold agglutinin disease in order to reduce the possibility of a transfusion reaction? A. Irradiate to prevent graft-versus-host-disease (GVHD) B. Wash with 0.9% percent saline C. Warm to 37°C with a blood warmer D. Transport so that temperature is maintained at 20 to 24°C

    C. Warm to 37°C with a blood warmer

  • 70

    Which of the following is an acceptable time in which a unit of whole blood is collected? A. 33 minutes B. 25 minutes C. 20 minutes D. 13 minutes

    D. 13 minutes

  • 71

    How much anticoagulant would have to be removed from the collection bag given a donor who weighs 90 lb? A. 12 mL B. 15 mL C. 20 mL D. 23 mL

    A. 12 mL

  • 72

    The minimum hemoglobin concentration in a finger stick from a female blood donor is: A. 12.0 g/dL (120 g/L) B. 12.5 g/dL (125 g/L) C. 13.0 g/dL (135 g/L) D. 15.0 g/dL (150 g/L)

    B. 12.5 g/dL (125 g/L)

  • 73

    Which of the following donors could be accepted for whole-blood donation? A. A construction worker who was incarcerated for opiate abuse B. A triathlete with a pulse of 45 C. A man who is currently taking finasteride (Propecia) D. A woman in her 14th week of pregnancy

    B. A triathlete with a pulse of 45

  • 74

    How often can a blood donor donate whole blood? A. Every 24 hours B. Once a month C. Every 8 weeks D. Twice a year

    C. Every 8 weeks

  • 75

    A donor who has just donated 2 units of Apheresis Red Blood Cells will be deferred from further blood donation for a minimum of how many weeks? A. 8 B. 12 C. 16 D. 24

    C. 16

  • 76

    All of the following apply to a double red cell unit apheresis collection except: A. The hematocrit must be at least 38% B. The weight for a female is at least 150 lbs C. The height for a male is at least 5 ft 1 in. D. The deferral period following collection is 16 weeks

    A. The hematocrit must be at least 38%

  • 77

    To qualify as a donor for autologous transfusion a patient’s hemoglobin should be at least: A. 8 g/dL B. 11 g/dL C. 13 g/dL D. 15 g/dL

    B. 11 g/dL

  • 78

    Which one of the following constitutes permanent deferral status of a donor? A. A tattoo 5 months previously B. Recent close contact with a patient with viral hepatitis C. 2 units of blood transfused 4 months previously D. Confirmed positive test for HBsAg 10 years previously

    D. Confirmed positive test for HBsAg 10 years previously

  • 79

    Donors who have received HBIG must wait ___ months to donate blood to be sure they were not infected since hepatitis B can be transmitted through transfusion to a patient. A. 2 weeks B. 1 month C. 3 months D. 12 months

    D. 12 months

  • 80

    Which of the following vaccinations carries no deferral period? A. Rubella B. Varicella zoster C. Recombinant HPV D. Smallpox

    C. Recombinant HPV

  • 81

    A donor bag is half filled during donation when the blood flow stops. Select the correct course of action. A. Closely observe the bag for at least 3 minutes; if blood flow does not resume, withdraw the needle B. Remove the needle immediately and discontinue the donation C. Check and reposition the needle if necessary; if blood flow does not resume, withdraw the needle D. Withdraw the needle and perform a second venipuncture in the other arm

    C. Check and reposition the needle if necessary; if blood flow does not resume, withdraw the needle

  • 82

    A woman begins to breathe rapidly while donating blood. Choose the correct course of action. A. Continue the donation; rapid breathing is not a reason to discontinue a donation B. Withdraw the needle, raise her feet, and administer ammonia C. Discontinue the donation and provide a paper bag D. Tell her to sit upright and apply a cold compress to her forehead

    C. Discontinue the donation and provide a paper bag

  • 83

    A unit tests positive for syphilis using the rapid plasma reagin test (RPR). The microhemagglutinin assayTreponema pallidum (MHA-TP) on the same unit is negative. What is the disposition of the unit? A. The unit may be used to prepare components B. The donor must be contacted and questioned further; if the RPR result is most likely a false positive, then the unit may be used C. The unit must be discarded D. Cellular components may be prepared but must be irradiated before issue

    A. The unit may be used to prepare components

  • 84

    John Smith donated a unit of whole blood in May. Red blood cells made from the whole blood were transfused to a recipient of a community hospital in June with no apparent complications. The blood supplier notified the medical director of the hospital that the donor reported HIGH-RISK BEHAVIOR with another male in April, although viral tests remain negative and the donor is healthy. What course of action should be taken? A. No action should be taken B. The recipient’s physician should be notified C. The recipient’s physician and the recipient should be notified D. The recipient should be notified

    B. The recipient’s physician should be notified

  • 85

    Rejuvenation of a unit of Red Blood Cells is a method used to: A. Remove antibody attached to RBCs B. Restore 2,3-DPG and ATP to normal levels C. Inactivate viruses and bacteria D. Filter blood clots and other debris

    B. Restore 2,3-DPG and ATP to normal levels

  • 86

    A technologist removed 4 units of blood from the blood bank refrigerator and placed them on the counter. A clerk was waiting to take the units for transfusion. As she checked the paperwork, she noticed that one of the units was leaking onto the counter. What should she do? A. Issue the unit if the red cells appear normal B. Reseal the unit C. Discard the unit D. Call the medical director and ask for an opinion

    C. Discard the unit

  • 87

    What should be done if a noticeable clot is found in an RBC unit? A. Issue the unit; the blood will be filtered B. Issue the unit; note the presence of a clot on the release form C. Filter the unit in the blood bank before issue D. Do not issue the unit

    D. Do not issue the unit

  • 88

    Upon inspection, a unit of Apheresis Platelets is noted to have visible clots, but otherwise appears normal. The technologist should: A. Issue without concern B. Filter to remove the clots C. Centrifuge to express off the clots D. Quarantine for Gram stain and culture

    D. Quarantine for Gram stain and culture

  • 89

    Plastic bag overwraps are recommended when thawing units of FFP in 37°C water baths because they prevent: A. The FFP bag from cracking when it contacts the warm water B. Water from slowly dialyzing across the bag membrane C. The entry ports from becoming contaminated with water D. The label from peeling off as the water circulates in the bath

    C. The entry ports from becoming contaminated with water

  • 90

    Which of the following anticoagulant preservative provides a storage time of 35 days at 1°C to 6°C for units of whole blood and prepared RBCs if an additive solution is not added? A. ACD B. CP2D C. CPD D. CPDA-1

    D. CPDA-1

  • 91

    Appropriate preservative for modified whole blood: A. ACD B. CPD C. CPDA-1 D. All of these

    D. All of these

  • 92

    All of the following are requirements for the tag on the crossmatched donor unit, EXCEPT: A. ABO and Rh type B. Name of the donor C. Unit expiration date D. Interpretation of the crossmatch

    B. Name of the donor

  • 93

    What is the expected therapeutic effect in the recipient’s hematocrit after the transfusion of 1 unit of RBCs? A. Increase of 0.5% B. Increase of 1% C. Increase of 2% D. Increase of 3%

    D. Increase of 3%

  • 94

    How many units of red blood cells are required to raise the hematocrit of a 70 kg nonbleeding man from 24% to 30%? A. 1 B. 2 C. 3 D. 4

    B. 2

  • 95

    A 42-year-old male of average body mass has a history of chronic anemia requiring transfusion support. Two units of red blood cells are transfused. If the pretransfusion hemoglobin was 7.0 g/dL, the expected posttransfusion hemoglobin concentration should be: A. 8.0 g/dL B. 9.0 g/dL C. 10.0 g/dL D. 11.0 g/dL

    B. 9.0 g/dL

  • 96

    Washed Red Blood Cells are indicated in which of the following situations? A. An IgA-deficient patient with a history of transfusion-associated anaphylaxis B. A pregnant woman with a history of hemolytic disease of the newborn C. A patient with a positive DAT and red cell autoantibody D. A newborn with a hematocrit of <30%

    A. An IgA-deficient patient with a history of transfusion-associated anaphylaxis

  • 97

    According to AABB Standards, LEUKOREDUCED RED CELLS is a product in which the absolute WBC count in the unit is reduced to ____, and contains at least ______ of the original RBC mass. A. 1 x 10^10, 85% B. 3.0 x 10^11, 85% C. 5.5 x 10^10, 85% D. 5 x 10^6, 85%

    D. 5 x 10^6, 85%

  • 98

    A unit of packed cells is split into 2 aliquots under CLOSED STERILE CONDITIONS at 8 AM. The expiration time for each aliquot is now: A. 4 PM on the same day B. 8 AM the next morning C. 8 PM on the same day D. The original date of the unsplit unit

    D. The original date of the unsplit unit

  • 99

    A unit of Red Blood Cells expiring in 35 days is split into 5 small aliquots using a sterile pediatric quad set and a sterile connecting device. Each aliquot must be labeled as expiring in: A. 6 hours B. 12 hours C. 5 days D. 35 days

    D. 35 days

  • 100

    A unit of packed RBCs is split using the OPEN SYSTEM. One of the half units is used. What may be done with the second half unit? A. Must be issued within 24 hours B. Must be issued within 48 hours C. Must be irradiated D. Must retain the original expiration date

    A. Must be issued within 24 hours

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    The key structural difference that distinguishes immunoglobulin subclasses is the: A. Number of domains B. Stereometry of the hypervariable region C. The sequence of the constant regions D. Covalent linkage of the light chains

    C. The sequence of the constant regions

  • 2

    lmmunoglobulin classes are differentiated according to the molecular structure of: A. Light chains B. Heavy chains C. Fab fragment D. Fc fragment

    B. Heavy chains

  • 3

    .A 54-year-old female previous smoker presents with a recent history of fever, swollen joints, and morning stiffness. § Laboratory results indicate elevated C-reactive protein, positive cyclic citrullinated peptide of 205 units (cut-off: 20 units), speckled ANA pattern (titer 1:320), and negative rheumatoid factor. What is the most likely diagnosis? A. Reactive arthritis B. Rheumatoid arthritis C. Systemic sclerosis D. Sjogren syndrome

    B. Rheumatoid arthritis

  • 4

    Which of the following is used for the confirmation of infection with HIV-1? A. Western blot (immunoblot) assay B. ELISA C. Complement fixation D. p24 Antigen testing

    A. Western blot (immunoblot) assay

  • 5

    Which technique is used for the confirmation of infection with HIV-1 and HIV-2? A. Western blot (immunoblot) assay B. ELISA C. FDA-approved NAT D. p24 Antigen testing

    C. FDA-approved NAT

  • 6

    Clinical assays for tumor markers are most important for: A. Screening for the presence of cancer B. Monitoring the course of a known cancer C. Confirming the absence of disease D. Identifying patients at risk for cancer

    B. Monitoring the course of a known cancer

  • 7

    . In general, in which of the following situations is the analysis of a tumor marker most useful? A. Testing for recurrence B. Prognosis C. Screening D. Diagnosis

    A. Testing for recurrence

  • 8

    The chemical composition of an antibody is: A. Protein B. Lipid C. Carbohydrate D. Glycoprotein

    D. Glycoprotein

  • 9

    What is the most common clinical incident that results in alloantibody production? A. Viral infection B. Solid tumor C. Red cell transfusion D. Autoimmune disease

    C. Red cell transfusion

  • 10

    What antibodies are present in polyspecific AHG reagent? A. Anti-IgG B. Anti-IgM and anti-IgG C. Anti-IgG and anti-C3d D. Anti-C3d

    C. Anti-IgG and anti-C3d

  • 11

    Which of the following medications is most likely to cause production of AUTOANTIBODIES? A. Penicillin B. Cephalosporin C. Methyldopa D. Tetracycline

    C. Methyldopa

  • 12

    Red cells from a recently transfused patient were DAT positive when tested with anti-IgG. Screen cells and a panel performed on a patient’s serum showed very weak reactions with inconclusive results. What procedure could help to identify the antibody? A. Elution followed by a panel on the eluate B. Adsorption followed by a panel on the adsorbed serum C. Enzyme panel D. Antigen typing the patient’s red cells

    A. Elution followed by a panel on the eluate

  • 13

    The procedure that removes intact antibodies from the red cell membranes is: A. Autoadsorption B. Enzyme pretreatment C. Neutralization D. Elution

    D. Elution

  • 14

    Crossmatch results at the antiglobulin phase were negative. When 1 drop of check cells was added, NO AGGLUTINATION was seen. The most likely explanation is that the: A. Red cells were overwashed B. Residual patient serum inactivated the AHG reagent C. Centrifuge speed was set too high D. Laboratorian did not add enough check cells

    B. Residual patient serum inactivated the AHG reagent

  • 15

    Autoantibodies demonstrating blood group specificity in warm autoimmune hemolytic anemia are associated more often with which blood group system? A. Rh B. I C. P D. Fy

    A. Rh

  • 16

    Which antibody is frequently seen in patients with warm autoimmune hemolytic anemia? A. Anti-Jka B. Anti-e C. Anti-K D. Anti-Fyb

    B. Anti-e

  • 17

    Many enhancement media used in the blood bank promote hemagglutination in the presence of lgG antibodies by reducing which of the following? A. Hydrophilic forces B. Low ionic potential C. van der Waals forces D. Zeta potential

    D. Zeta potential

  • 18

    Low ionic strength saline (LISS) acts as an enhancement medium and facilitates antibody uptake by: A. Activating complement B. Increasing flexibility in hinge region C. Removing water molecules D. Reducing zeta potential

    D. Reducing zeta potential

  • 19

    Which antibody would not be detected by group O screening cells? A. Anti-N B. Anti-A1 C. Anti-Dia D. Anti-k

    B. Anti-A1

  • 20

    Screening cells, major crossmatch, and patient autocontrol are positive in all phases. Identify the problem. A. Specific cold alloantibody B. Specific cold autoantibody C. Abnormal protein or nonspecific autoantibody D. Cold and warm alloantibody mixture

    C. Abnormal protein or nonspecific autoantibody

  • 21

    What corrective action should be taken when rouleaux causes positive test results? A. Perform a saline replacement technique B. Perform an autoabsorption C. Run a panel D. Perform an elution

    A. Perform a saline replacement techniqu

  • 22

    . Screening cells and major crossmatch are positive on IS only, and the autocontrol is negative. Identify the problem. A. Cold alloantibody B. Cold autoantibody C. Abnormal protein D. Antibody mixture

    A. Cold alloantibody

  • 23

    Which of the following describes the expression of most blood group inheritance? A. Dominant B. Sex-linked C. Recessive D. Codominant

    D. Codominant

  • 24

    Which genotype(s) will give rise to the Bombay phenotype? A. HH only B. HH and Hh C. Hh and hh D. hh only

    D. hh only

  • 25

    What should be done if all forward and reverse ABO results as well as the autocontrol are positive? A. Wash the cells with warm saline, autoadsorb the serum at 4°C B. Retype the sample using a different lot number of reagents C. Use polyclonal typing reagents D. Report the sample as group AB

    A. Wash the cells with warm saline, autoadsorb the serum at 4°C

  • 26

    A patient types as AB positive. Two units of blood have been ordered by the physician. Currently, the inventory shows no AB units, 10 A-positive units, 1 Anegative unit, 5 B-positive units, and 20 O-positive units. Which should be set up for the major crossmatch? A. A-positive units B. O-positive units C. B-positive units D. Call another blood supplier for type-specific blood

    A. A-positive units

  • 27

    A physician orders 2 units of leukocyte-reduced red blood cells. The patient is a 55-year-old male with anemia. He types as an AB negative, and his antibody screen is negative. There is only 1 unit of AB negative in inventory. What is the next blood type that should be given? A. AB positive (patient is male) B. A negative C. B negative D. O negative

    B. A negative

  • 28

    In an emergency situation, Rh-negative red cells are transfused into an Rh-positive person of the genotype CDe/CDe. The first antibody most likely to develop is: A. Anti-c B. Anti-d C. Anti-e D. Anti-E

    A. Anti-c

  • 29

    What antibodies could an R1R1 make if exposed to R2R2 blood? A. Anti-e and anti-C B. Anti-E and anti-c C. Anti-E and anti-C D. Anti-e and anti-c

    B. Anti-E and anti-c

  • 30

    What techniques are necessary for weak D testing? A. Saline + 22°C incubation B. Albumin or LISS + 37°C incubation C. Saline + 37°C incubation D. 37°C incubation + IAT

    D. 37°C incubation + IAT

  • 31

    RhIg (Rhogam) is indicated for: A. Mothers who have anti-D B. Infants who are Rh-negative C. Infants who have anti-D D. Mothers who are Rh-negative

    D. Mothers who are Rh-negative

  • 32

    .RhIG should be administered within how many hours of delivery? A. 4 B. 48 C. 72 D. 96

    C. 72

  • 33

    Which of the following antigens is poorly expressed on cord blood cells? A. K B. M C. Leb D. D

    C. Leb

  • 34

    Which of the following is characteristic of anti-i? A. Often associated with hemolytic disease of the newborn B. Reacts best at 37ºC C. Reacts best at room temperature or 4ºC D. Is usually IgG

    C. Reacts best at room temperature or 4ºC

  • 35

    PAROXYSMAL COLD HEMOGLOBINURIA (PCH) is associated with antibody specificity toward which of the following? A. Kell system antigens B. Duffy system antigens C. P antigen D. I antigen

    C. P antigen

  • 36

    In the DONATH-LANDSTEINER TEST, patient’s serum are incubated at various temperatures with: A. Group O RBCs that express the P antigen B. Group O RBCs that express the P1 antigen C. Group AB RBCs that express the P antigen D. Group AB RBCs that express the P1 antigen

    A. Group O RBCs that express the P antigen

  • 37

    Excluding ABO, __ is rated second only to D in immunogenicity. A. Kell B. Cellano C. Duffy D. Kidd

    A. Kell

  • 38

    The K (KEL1) antigen is: A. Absent from the red cells of neonates B. Strongly immunogenic C. Destroyed by enzymes D. Has a frequency of 50% in the random population

    B. Strongly immunogenic

  • 39

    The k (Cellano) antigen is a high-frequency antigen and is found on most red cells. How often would one expect to find the corresponding antibody? A. Often B. Rarely C. It depends upon the population D. Impossible to determine without consulting regional blood group antigen charts

    B. Rarely

  • 40

    An individual has been sensitized to the k antigen and has produced anti-k. What is her most probable Kell system genotype? A. KK B. Kk C. kk D. K0K0

    A. KK

  • 41

    An antibody commonly associated with delayed transfusion reactions is: A. Anti-Lua B. Anti-S C. Anti-Jkb D. Anti-M

    C. Anti-Jkb

  • 42

    What blood group system antibodies are commonly associated with delayed hemolytic transfusion reactions? A. Rh c B. MNS C. ABO D. Kidd

    D. Kidd

  • 43

    What procedure would help to distinguish between an anti-Fya and anti-Jka in an antibody mixture? A. Lowering the pH of the patient’s serum B. Using a thiol reagent C. Testing at colder temperatures D. Ficin-treated panel cells

    D. Ficin-treated panel cells

  • 44

    Which of the following antibodies characteristically gives a refractile mixed-field appearance? A. Anti-K B. Anti-Dia C. Anti-Sda D. Anti-s

    C. Anti-Sda

  • 45

    A patient has symptoms indicating a possible hemolytic transfusion reaction. What should be done immediately? A. Stop the transfusion and discard the unit B. Contact the patient's doctor to ask if the transfusion should be stopped C. Stop the transfusion and call the patient's doctor to report the reaction D. Have patient blood samples sent to the lab to investigate the reaction

    C. Stop the transfusion and call the patient's doctor to report the reaction

  • 46

    FATAL TRANSFUSION reactions are mostly caused by? A. Serologic errors B. Improper storage of blood C. Clerical errors D. Improper handling of the product

    C. Clerical errors

  • 47

    Some blood group antibodies characteristically hemolyze appropriate red cells in the presence of: A. Complement B. Anticoagulants C. Preservatives D. Penicillin

    A. Complement

  • 48

    PAIN AT INFUSION SITE and hypotension are observed with what type of reaction? A. Acute hemolytic transfusion reaction B. Allergic reaction C. Delayed hemolytic transfusion reaction D. Febrile nonhemolytic reaction

    A. Acute hemolytic transfusion reaction

  • 49

    Hypotension, nausea, flushing, fever and chills are symptoms of which of the following transfusion reactions? A. Allergic B. Circulatory overload C. Hemolytic D. Anaphylactic

    C. Hemolytic

  • 50

    Hemoglobinuria, hypotension and generalized bleeding are symptoms of which of the following transfusion reactions? A. Allergic B. Circulatory overload C. Hemolytic D. Anaphylactic

    C. Hemolytic

  • 51

    The most serious hemolytic transfusion reactions are due to incompatibility in which of the following blood group systems? A. ABO B. Rh C. MN D. Duffy

    A. ABO

  • 52

    What would be the result of group A blood given to an O patient? A. Nonimmune transfusion reaction B. Immediate hemolytic transfusion reaction C. Delayed hemolytic transfusion reaction D. Febrile nonhemolytic transfusion reaction

    B. Immediate hemolytic transfusion reaction

  • 53

    A patient has a hemolytic reaction to blood transfused 8 days ago. What is the most likely cause? A. Immediate, nonimmunologic probably due to volume overload B. Delayed immunologic, probably due to an antibody such as anti-Jka C. Delayed nonimmunologic, probably due to iron overload D. Immediate, immunologic, probably due to clerical error, ABO incompatibility

    B. Delayed immunologic, probably due to an antibody such as anti-Jka

  • 54

    In a DELAYED TRANSFUSION REACTION, the causative antibody is generally too weak to be detected in routine compatibility testing and antibody screening tests, but is typically detectable at what point after transfusion? A. 3 - 6 hours B. 3 - 7 days C. 60 - 90 days D. After 120 days

    B. 3 - 7 days

  • 55

    An unexplained fall in hemoglobin and mild jaundice in a patient transfused with Red Blood Cells 1 week previously would most likely indicate: A. Paroxysmal nocturnal hemoglobinuria B. Posttransfusion hepatitis infection C. Presence of HLA antibodies D. Delayed hemolytic transfusion reaction

    D. Delayed hemolytic transfusion reaction

  • 56

    Fever and chills are symptoms of which of the following transfusion reactions? A. Citrate toxicity B. Circulatory overload C. Allergic D. Febrile

    D. Febrile

  • 57

    Symptoms of dyspnea, hypoxemia, and pulmonary edema within 6 hours of transfusion is most likely which type of reaction? A. Anaphylactic B. Hemolytic C. Febrile D. TRALI

    D. TRALI

  • 58

    What may be found in the serum of a person who is exhibiting signs of TRALI (transfusion-related acute lung injury)? A. Red blood cell alloantibody B. IgA antibody C. Anti-leukocyte antibody D. Allergen

    C. Anti-leukocyte antibody

  • 59

    Hives and itching are symptoms of which of the following transfusion reactions? A. Febrile B. Allergic C. Circulatory overload D. Bacterial

    B. Allergic

  • 60

    Which of the following transfusion reactions occurs after infusion of only a few milliliters of blood and gives no history of fever? A. Febrile B. Circulatory overload C. Anaphylactic D. Hemolytic

    C. Anaphylactic

  • 61

    Anaphylactic reactions to transfusion are usually caused by: A. Anti-IgA in an IgA-deficient recipient B. Anti-IgG in an IgA-deficient C. IgA deficiency D. IgG deficiency

    A. Anti-IgA in an IgA-deficient recipient

  • 62

    Which of the following transfusion reactions is characterized by high fever, shock, hemoglobinuria, DIC and renal failure? A. Bacterial contamination B. Circulatory overload C. Febrile D. Anaphylactic

    A. Bacterial contamination

  • 63

    Coughing, hypoxemia and difficult breathing are symptoms of which of the following transfusion reactions? A. Febrile B. Allergic C. TACO D. Hemolytic

    C. TACO

  • 64

    Congestive heart failure, severe headache and/or peripheral edema occurring soon after transfusion is indicative of which type of transfusion reaction? A. Hemolytic B. Febrile C. Anaphylactic D. TACO

    D. TACO

  • 65

    Which of the following patient groups is at risk of developing graft-versus-host disease? A. Full-term infants B. Patients with history of febrile transfusion reactions C. Patients with a positive direct antiglobulin test D. Recipients of blood donated by immediate family members

    D. Recipients of blood donated by immediate family members

  • 66

    The most frequent transfusion-associated disease complication of blood transfusions is: A. Cytomegalovirus (CMV) B. Syphilis C. Hepatitis D. HIV-1/2

    C. Hepatitis

  • 67

    When evaluating a possible delayed hemolytic reaction, what is the best sample to use for bilirubin determination? A. 6 hours posttransfusion B. 12 hours posttransfusion C. 24 hours posttransfusion D. 48 hours posttransfusion

    A. 6 hours posttransfusion

  • 68

    What is the primary reason that infectious agents can be transmitted following blood transfusion? A. Pathogen reduction technology failure B. Donor in the window period of early infection C. Leukocyte-reduction failure D. Donor history questionnaire not completed

    B. Donor in the window period of early infection

  • 69

    . What may be done to RBCs before transfusion to a patient with cold agglutinin disease in order to reduce the possibility of a transfusion reaction? A. Irradiate to prevent graft-versus-host-disease (GVHD) B. Wash with 0.9% percent saline C. Warm to 37°C with a blood warmer D. Transport so that temperature is maintained at 20 to 24°C

    C. Warm to 37°C with a blood warmer

  • 70

    Which of the following is an acceptable time in which a unit of whole blood is collected? A. 33 minutes B. 25 minutes C. 20 minutes D. 13 minutes

    D. 13 minutes

  • 71

    How much anticoagulant would have to be removed from the collection bag given a donor who weighs 90 lb? A. 12 mL B. 15 mL C. 20 mL D. 23 mL

    A. 12 mL

  • 72

    The minimum hemoglobin concentration in a finger stick from a female blood donor is: A. 12.0 g/dL (120 g/L) B. 12.5 g/dL (125 g/L) C. 13.0 g/dL (135 g/L) D. 15.0 g/dL (150 g/L)

    B. 12.5 g/dL (125 g/L)

  • 73

    Which of the following donors could be accepted for whole-blood donation? A. A construction worker who was incarcerated for opiate abuse B. A triathlete with a pulse of 45 C. A man who is currently taking finasteride (Propecia) D. A woman in her 14th week of pregnancy

    B. A triathlete with a pulse of 45

  • 74

    How often can a blood donor donate whole blood? A. Every 24 hours B. Once a month C. Every 8 weeks D. Twice a year

    C. Every 8 weeks

  • 75

    A donor who has just donated 2 units of Apheresis Red Blood Cells will be deferred from further blood donation for a minimum of how many weeks? A. 8 B. 12 C. 16 D. 24

    C. 16

  • 76

    All of the following apply to a double red cell unit apheresis collection except: A. The hematocrit must be at least 38% B. The weight for a female is at least 150 lbs C. The height for a male is at least 5 ft 1 in. D. The deferral period following collection is 16 weeks

    A. The hematocrit must be at least 38%

  • 77

    To qualify as a donor for autologous transfusion a patient’s hemoglobin should be at least: A. 8 g/dL B. 11 g/dL C. 13 g/dL D. 15 g/dL

    B. 11 g/dL

  • 78

    Which one of the following constitutes permanent deferral status of a donor? A. A tattoo 5 months previously B. Recent close contact with a patient with viral hepatitis C. 2 units of blood transfused 4 months previously D. Confirmed positive test for HBsAg 10 years previously

    D. Confirmed positive test for HBsAg 10 years previously

  • 79

    Donors who have received HBIG must wait ___ months to donate blood to be sure they were not infected since hepatitis B can be transmitted through transfusion to a patient. A. 2 weeks B. 1 month C. 3 months D. 12 months

    D. 12 months

  • 80

    Which of the following vaccinations carries no deferral period? A. Rubella B. Varicella zoster C. Recombinant HPV D. Smallpox

    C. Recombinant HPV

  • 81

    A donor bag is half filled during donation when the blood flow stops. Select the correct course of action. A. Closely observe the bag for at least 3 minutes; if blood flow does not resume, withdraw the needle B. Remove the needle immediately and discontinue the donation C. Check and reposition the needle if necessary; if blood flow does not resume, withdraw the needle D. Withdraw the needle and perform a second venipuncture in the other arm

    C. Check and reposition the needle if necessary; if blood flow does not resume, withdraw the needle

  • 82

    A woman begins to breathe rapidly while donating blood. Choose the correct course of action. A. Continue the donation; rapid breathing is not a reason to discontinue a donation B. Withdraw the needle, raise her feet, and administer ammonia C. Discontinue the donation and provide a paper bag D. Tell her to sit upright and apply a cold compress to her forehead

    C. Discontinue the donation and provide a paper bag

  • 83

    A unit tests positive for syphilis using the rapid plasma reagin test (RPR). The microhemagglutinin assayTreponema pallidum (MHA-TP) on the same unit is negative. What is the disposition of the unit? A. The unit may be used to prepare components B. The donor must be contacted and questioned further; if the RPR result is most likely a false positive, then the unit may be used C. The unit must be discarded D. Cellular components may be prepared but must be irradiated before issue

    A. The unit may be used to prepare components

  • 84

    John Smith donated a unit of whole blood in May. Red blood cells made from the whole blood were transfused to a recipient of a community hospital in June with no apparent complications. The blood supplier notified the medical director of the hospital that the donor reported HIGH-RISK BEHAVIOR with another male in April, although viral tests remain negative and the donor is healthy. What course of action should be taken? A. No action should be taken B. The recipient’s physician should be notified C. The recipient’s physician and the recipient should be notified D. The recipient should be notified

    B. The recipient’s physician should be notified

  • 85

    Rejuvenation of a unit of Red Blood Cells is a method used to: A. Remove antibody attached to RBCs B. Restore 2,3-DPG and ATP to normal levels C. Inactivate viruses and bacteria D. Filter blood clots and other debris

    B. Restore 2,3-DPG and ATP to normal levels

  • 86

    A technologist removed 4 units of blood from the blood bank refrigerator and placed them on the counter. A clerk was waiting to take the units for transfusion. As she checked the paperwork, she noticed that one of the units was leaking onto the counter. What should she do? A. Issue the unit if the red cells appear normal B. Reseal the unit C. Discard the unit D. Call the medical director and ask for an opinion

    C. Discard the unit

  • 87

    What should be done if a noticeable clot is found in an RBC unit? A. Issue the unit; the blood will be filtered B. Issue the unit; note the presence of a clot on the release form C. Filter the unit in the blood bank before issue D. Do not issue the unit

    D. Do not issue the unit

  • 88

    Upon inspection, a unit of Apheresis Platelets is noted to have visible clots, but otherwise appears normal. The technologist should: A. Issue without concern B. Filter to remove the clots C. Centrifuge to express off the clots D. Quarantine for Gram stain and culture

    D. Quarantine for Gram stain and culture

  • 89

    Plastic bag overwraps are recommended when thawing units of FFP in 37°C water baths because they prevent: A. The FFP bag from cracking when it contacts the warm water B. Water from slowly dialyzing across the bag membrane C. The entry ports from becoming contaminated with water D. The label from peeling off as the water circulates in the bath

    C. The entry ports from becoming contaminated with water

  • 90

    Which of the following anticoagulant preservative provides a storage time of 35 days at 1°C to 6°C for units of whole blood and prepared RBCs if an additive solution is not added? A. ACD B. CP2D C. CPD D. CPDA-1

    D. CPDA-1

  • 91

    Appropriate preservative for modified whole blood: A. ACD B. CPD C. CPDA-1 D. All of these

    D. All of these

  • 92

    All of the following are requirements for the tag on the crossmatched donor unit, EXCEPT: A. ABO and Rh type B. Name of the donor C. Unit expiration date D. Interpretation of the crossmatch

    B. Name of the donor

  • 93

    What is the expected therapeutic effect in the recipient’s hematocrit after the transfusion of 1 unit of RBCs? A. Increase of 0.5% B. Increase of 1% C. Increase of 2% D. Increase of 3%

    D. Increase of 3%

  • 94

    How many units of red blood cells are required to raise the hematocrit of a 70 kg nonbleeding man from 24% to 30%? A. 1 B. 2 C. 3 D. 4

    B. 2

  • 95

    A 42-year-old male of average body mass has a history of chronic anemia requiring transfusion support. Two units of red blood cells are transfused. If the pretransfusion hemoglobin was 7.0 g/dL, the expected posttransfusion hemoglobin concentration should be: A. 8.0 g/dL B. 9.0 g/dL C. 10.0 g/dL D. 11.0 g/dL

    B. 9.0 g/dL

  • 96

    Washed Red Blood Cells are indicated in which of the following situations? A. An IgA-deficient patient with a history of transfusion-associated anaphylaxis B. A pregnant woman with a history of hemolytic disease of the newborn C. A patient with a positive DAT and red cell autoantibody D. A newborn with a hematocrit of <30%

    A. An IgA-deficient patient with a history of transfusion-associated anaphylaxis

  • 97

    According to AABB Standards, LEUKOREDUCED RED CELLS is a product in which the absolute WBC count in the unit is reduced to ____, and contains at least ______ of the original RBC mass. A. 1 x 10^10, 85% B. 3.0 x 10^11, 85% C. 5.5 x 10^10, 85% D. 5 x 10^6, 85%

    D. 5 x 10^6, 85%

  • 98

    A unit of packed cells is split into 2 aliquots under CLOSED STERILE CONDITIONS at 8 AM. The expiration time for each aliquot is now: A. 4 PM on the same day B. 8 AM the next morning C. 8 PM on the same day D. The original date of the unsplit unit

    D. The original date of the unsplit unit

  • 99

    A unit of Red Blood Cells expiring in 35 days is split into 5 small aliquots using a sterile pediatric quad set and a sterile connecting device. Each aliquot must be labeled as expiring in: A. 6 hours B. 12 hours C. 5 days D. 35 days

    D. 35 days

  • 100

    A unit of packed RBCs is split using the OPEN SYSTEM. One of the half units is used. What may be done with the second half unit? A. Must be issued within 24 hours B. Must be issued within 48 hours C. Must be irradiated D. Must retain the original expiration date

    A. Must be issued within 24 hours